Al-Jondeby Mohamed S, Cabaguing Iolani T, Pajarillo Amelita A, Hawas Fahd A, Mousa Dujanah H, Al-Sulaiman Mohamed H, Shaheen Faissal A, Al-Khader Abdulla A
Department Nephrology, Armed Forces Hospital, Riyadh, Kingdom of Saudi Arabia.
Saudi Med J. 2003 Mar;24(3):265-8.
There is relatively little clinical experience reported on the use of the vitamin E coated dialyzer (CL-EE12, Terumo). This study compares its efficacy and intradialytic symptoms with a polysulphone dialyzer in 2 groups of patients in a controlled crossover trial design.
This study was carried out at the Armed Forces Hospital, Riyadh, Kingdom of Saudi Arabia, during the time period January to March 2002. In group A, 34 patients were dialyzed for 4 weeks with vitamin E dialyzer then switched over to Fresenius 60 (F60) for 4 weeks. In group B, 41 patients were dialyzed with F60 for 4 weeks then switched to vitamin E coated dilayzers for 4 weeks. The following parameters were measured weekly, hemoglobin level, urea reduction ratio (URR), urea clearance ratio (Kt/V), pre and post dialysis diastolic blood pressure (DBP) and systolic blood pressure (SBP), interdialytic weight gain. The patients were observed for interdialytic hypotension or symptoms.
No significant findings were found in any of the parameters except more dialyzer clotting was observed with vitamin E dialyzer than in F60 dialyzers (1.6% of dialysis sessions versus 0.1% P<0.03). The interdialytic weight gain tended to be less in the vitamin E group but did not reach statistically significant difference. The Kt/V and URR were slightly higher when using the vitamin E dialyzer only in the second and third weeks. hypotensive episodes (P<.007) less leg cramp (P<.31) and less itching (P<.02) in the vitamin E coated treated group within group B.
There were only minor differences noted between the 2 dialyzers in the parameters measured.
关于使用维生素E涂层透析器(CL-EE12,泰尔茂公司)的临床经验报道相对较少。本研究采用对照交叉试验设计,比较两组患者中其与聚砜透析器的疗效及透析过程中的症状。
本研究于2002年1月至3月在沙特阿拉伯利雅得的武装部队医院进行。A组34例患者先用维生素E透析器透析4周,然后改用费森尤斯60(F60)透析器透析4周。B组41例患者先用F60透析器透析4周,然后改用维生素E涂层透析器透析4周。每周测量以下参数:血红蛋白水平、尿素清除率(URR)、尿素清除比值(Kt/V)、透析前后的舒张压(DBP)和收缩压(SBP)、透析间期体重增加量。观察患者透析间期的低血压情况或症状。
除观察到维生素E透析器比F60透析器有更多的透析器凝血情况(透析疗程的1.6%对0.1%,P<0.03)外,在任何参数上均未发现显著差异。维生素E组透析间期体重增加量有减少趋势,但未达到统计学显著差异。仅在第二周和第三周使用维生素E透析器时,Kt/V和URR略高。B组中接受维生素E涂层透析器治疗的组低血压发作较少(P<0.007)、腿部痉挛较少(P<0.31)且瘙痒较少(P<0.02)。
在所测量的参数方面,两种透析器之间仅存在微小差异。